26
|
Khalil J, Elkacemi H, Sahli N, El Omrani F, Kebdani T, Benjaafar N. 2730 Quality of life in long-term cervical cancer survivors: Results from a single institution. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31497-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
27
|
Saadi A, Tazi M, Er-raki A, Benjaafar N, Bennani Mechida N, Mrabet M, Razine R. Analyse de survie au cancer du col de l’utérus à Rabat (Maroc) de 2005 à 2008. Rev Epidemiol Sante Publique 2015. [DOI: 10.1016/j.respe.2015.03.107] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
28
|
Khalil J, Bellefqih S, Afif M, Elkacemi H, Kebdani T, Benjaafar N. Prognostic factors affecting cervical adenocarcinoma: 10 years experience in a single institution. Arch Gynecol Obstet 2015; 292:915-21. [DOI: 10.1007/s00404-015-3701-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Accepted: 03/24/2015] [Indexed: 11/28/2022]
|
29
|
Bellefqih S, Mezouri I, Khalil J, Bazine A, Diakité A, El Kacimi H, Kebdani T, Benjaafar N. [Primary central nervous lymphoma: what is the role for radiotherapy?]. Cancer Radiother 2014; 18:685-92. [PMID: 25451676 DOI: 10.1016/j.canrad.2014.06.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2014] [Revised: 05/23/2014] [Accepted: 06/06/2014] [Indexed: 10/24/2022]
Abstract
Primary central nervous system lymphoma is a rare extranodal form of non-Hodgkin lymphoma with an aggressive course and unsatisfactory outcome. Historically, whole-brain radiotherapy was the sole treatment for patients with primary central nervous system lymphoma, with high response rates but typically, this did not result in long-lasting remissions. The addition of high-dose methotrexate-based chemotherapy regimens to whole-brain radiotherapy has significantly improved patients' outcome, but has resulted in a higher incidence of late neurotoxicity, particularly in elderly patients. To date, the role of consolidation radiotherapy is controversial, and some investigators have developed alternative strategies aiming at avoiding immediate irradiation or using a reduced radiotherapy dose to the whole-brain with promising results.
Collapse
|
30
|
Bellefqih S, Khalil J, Mezouri I, ElKacemi H, Kebdani T, Hadadi K, Benjaafar N. [Concomitant chemoradiotherapy for muscle-invasive bladder cancer: current knowledge, controversies and future directions]. Cancer Radiother 2014; 18:779-89. [PMID: 25454383 DOI: 10.1016/j.canrad.2014.08.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2014] [Revised: 07/23/2014] [Accepted: 08/06/2014] [Indexed: 01/04/2023]
Abstract
Radical cystectomy with lymphadenectomy is currently the standard of care for muscle-invasive urothelial bladder cancer; however and because of its morbidity and its impact on quality of life, there is a growing tendency for bladder-sparing strategies. Initially reserved for elderly or unfit patients unable to undergo radical cystectomy, chemoradiotherapy became a true alternative to surgery for highly selected patients. Although there are no randomized trials comparing radical cystectomy with bladder preserving approaches, surgery remains the preferred treatment for many clinicians. Furthermore, comparison is even more difficult as modalities of radiotherapy are not consensual and differ between centers with a variability of protocols, volume of irradiation and type of chemotherapy. Several ongoing trials are attempting to optimize chemoradiotherapy and limit its toxicity, especially through techniques of adaptive radiotherapy or targeted therapies.
Collapse
|
31
|
Bellefqih S, Khalil J, Mezouri I, Afif M, Elmajjaoui S, Kebdani T, Benjaafar N. [Superior vena cava syndrome with malignant causes]. REVUE DE PNEUMOLOGIE CLINIQUE 2014; 70:343-352. [PMID: 25457217 DOI: 10.1016/j.pneumo.2014.08.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2014] [Revised: 08/11/2014] [Accepted: 08/17/2014] [Indexed: 06/04/2023]
Abstract
Superior vena cava syndrome comprises various symptoms and signs resulting from the obstruction of the superior vena cava and resulting in reduced blood flow. Superior vena cava may occur secondary to a variety of conditions, but malignant etiologies are the most common. Usually, the diagnosis is based on a quite clear clinical presentation. Patient with acute presentation can develop life-threatening complications such as cerebral or laryngeal edema. In the absence of these two conditions, a histologic diagnosis should be obtained before the initiation of any therapy. Management of superior vena cava syndrome requires a multidisciplinary team. Therapeutic approaches include radiotherapy, chemotherapy and endovascular approach, and the choice of therapy will depend on the severity of the symptoms, the type and the stage of the tumor, but also the patient's general condition.
Collapse
|
32
|
Bellefqih S, Khalil J, Mezouri I, ElKacemi H, Kebdani T, Hadadi K, Benjaafar N. Chimioradiothérapie concomitante des tumeurs infiltrantes de la vessie : acquis, controverses et perspectives. Cancer Radiother 2014. [DOI: 10.1016/j.canrad.2014.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
33
|
Bellefqih S, Khalil J, Mezouri I, ElKacimi H, Kebdani T, Hadadi K, Benjaafar N. Chimioradiothérapie concomitante des tumeurs infiltrantes de la vessie : acquis, controverses et perspectives. Cancer Radiother 2014. [DOI: 10.1016/j.canrad.2014.10.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
34
|
Mouhajir N, Diakité A, Toulba A, Hemmich M, Saadi I, Elkacemi H, Kebdani T, Benjaafar N. Primary Non-Hodgkin's Lymphoma of the Uterine Cervix: Case Report of Long-Term Survival Patient. J Obstet Gynaecol India 2014; 64:145-7. [PMID: 25404844 DOI: 10.1007/s13224-013-0483-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2013] [Accepted: 10/14/2013] [Indexed: 11/25/2022] Open
|
35
|
Bellefqih S, Mezouri I, Khalil J, Bazine A, Diakité A, El Kacimi H, Kebdani T, Benjaafar N. Lymphome primitif du système nerveux central : quel rôle pour la radiothérapie ? Cancer Radiother 2014. [DOI: 10.1016/j.canrad.2014.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
36
|
Bellefqih S, Mezouri I, Khalil J, Bazine A, Diakité A, Kacimi HE, Kebdani T, Benjaafar N. Lymphome primitif du système nerveux central : quel rôle pour la radiothérapie ? Cancer Radiother 2014. [DOI: 10.1016/j.canrad.2014.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
37
|
Diakité A, Bakkali H, Tolba A, Mariem H, Mouhajir N, Diabaté K, Nouh M, N’koua B, Boutayeb S, Kebdani T, Elgueddari BK, Ahid S, Benjaafar N. Curiethérapie à haute dose dans le cancer du col utérin : utilisation de l’applicateur en anneau. ACTA ACUST UNITED AC 2014. [DOI: 10.1007/s12558-014-0330-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
38
|
Bellefqih S, Khalil J, Mezouri I, Kebdani T, Benjaafar N. [Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature]. Cancer Radiother 2014; 18:201-7. [PMID: 24656987 DOI: 10.1016/j.canrad.2014.01.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2013] [Revised: 01/16/2014] [Accepted: 01/30/2014] [Indexed: 11/19/2022]
Abstract
Neuroendocrine carcinoma is a rare and aggressive malignant tumour, mainly developing at the expense of the respiratory and of the digestive tract. Gynecological neuroendocrine tumours are rare and small cell neuroendocrine tumours of the uterine cervix represent 2% of cervical cancer. Given their rarity and the lack of randomized trials, the diagnostic and therapeutic management of these tumors is difficult and essentially based on that of pulmonary neuroendocrine tumours. Like the latter, and despite multimodality regimens, the prognosis of these tumours remains poor. Through this series, we report our experience in the management of these particular tumours while comparing our data with those of the literature.
Collapse
|
39
|
Lachgar A, Diakité A, Kebdani T, El Gueddari B, Benjaafar N. Exacerbation de la douleur après radiothérapie antalgique de métastases osseuses. Cancer Radiother 2013. [DOI: 10.1016/j.canrad.2013.07.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
40
|
Diakité A, Bakkali H, Kebdani T, Benjaafar N. Curiethérapie de haut débit de dose dans le cancer du col utérin : utilisation de l’applicateur en anneau, à propos de 105 cas. Cancer Radiother 2013. [DOI: 10.1016/j.canrad.2013.07.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
41
|
Lachgar A, Afif M, Kebdani T, El Gueddari B, Benjaafar N. Résultats thérapeutiques de 33 patients atteints d’un cancer du nasopharynx avec atteinte des nerfs crâniens. Cancer Radiother 2013. [DOI: 10.1016/j.canrad.2013.07.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
42
|
Raissouni S, Rais G, Lkhoyaali S, Aitelhaj M, Mouzount H, Mokrim M, Razine R, El Kacemi H, Mrabti H, Benjaafar N, Errihani H. Clinical prognostic factors in locally advanced nasopharyngeal carcinoma in Moroccan population. Gulf J Oncolog 2013; 1:35-44. [PMID: 23996865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/07/2013] [Indexed: 06/02/2023]
Abstract
BACKGROUND Nasopharyngeal carcinoma is a distinct cancer of head and neck by its pathology, etiology, epidemiology and clinical behavior. Morocco is considered an endemic region with intermediate incidence. The aim of our report is to underline some clinical determinants of survival in locally advanced disease. PATIENTS AND METHODS We conducted a retrospective study from January 2003 to December 2005. All patients with undifferentiated nasopharyngeal carcinoma treated in the National Institute of Oncology of Rabat, Morocco were recorded. Classified stage II to IVB disease according to TNM classification adopted by the AJCC (American Joint Committee of Cancer) 6th edition. RESULTS The study included 339 patients, 122 women and 217 men (sex-ratio: 1.7). Mean age was 43 years old (range: 6-91years). Median duration to diagnosis was 6 months (range: 1-72) presenting symptoms at diagnosis were predominantly cervical lymph node in 79%. Forty- two patients have T1 tumors, 159 = T2 tumors, 64 = T3 tumors and 69 = T4 tumors. Sixty-five patients do not have lymph-node involvement, 49 have N1, 128 have N2 and 95 have N3. Three patients were at stage IIA, 57 patients were at stage IIB, 40 patients were at stage III, and 57 patients were at stage IVA and the remaining 96 patients were at stage IVB. Eighty-seven percent of patients underwent sequential chemoradiation and 17% underwent concurrent chemo-radiation (CTR). Response to induction chemotherapy was assessed in 235 patients. There were 31 patients with complete response and 59 patients have partial response. Complete response to radiotherapy was reached in 235 patients. Mean overall survival (OS) was 66.2%. Gender was a prognostic factor of OS (p=0.045) and DFS favoring women. Age wasn't a prognostic factors determining the outcome with no difference between patients aged more than 40 years old and patients younger. Tumor size was not a determinant of survival with a non-significant p in OS and DFS (0.27 and 0.46 respectively) but T4 stage patients appear to have a worse prognosis. Lymph node involvement was significantly determining the outcome either in OS and DFS (p=0.001 and 0.009 respectively). TNM stage was also a significant prognostic factor in OS but not in DFS favoring those with early stage (p= 0, 004 and p= 0, 13 respectively). The treatment strategy was not a significant prognostic factor with no difference between patients who underwent sequential or concurrent chemoradiation (OS p= 0, 48 and DFS p= 0, 9). In multivariate analysis, lymph-node involvement is the most significant factor. CONCLUSION Our findings were mostly concordant with the literature data in endemic areas for TNM staging; however we are limited by the bias of retrospective studies. Prospective studies would be more accurate to define those prognostic factors in our population. KEYWORDS UCNT, prognostic factors, endemic areas, lymph node involvement.
Collapse
|
43
|
Belbaraka R, Lalya I, Boulaamane L, Tazi M, Benjaafar N, Errihani H. [Dietary risk factors of undifferenced nasopharyngeal carcinoma : a case-control study]. LA TUNISIE MEDICALE 2013; 91:406-409. [PMID: 23868040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
BACKGROUND The incidence of nasopharyngeal carcinoma (NPC) is relatively high in Maghreb countries. This cancer is a model of multifactorial oncogenesis, but the role of food as risk factor in ethiopathogenesis of this tumor is not negligible. AIM To identify the association between risk of NPC and some dietary factors in Morocco. METHODS It is a case-control study including all new cases of NPC in our department between December 2009 and May 2010. Frequency consummation of foods was compared between cases and controls matched for age, sex and socio economic level. A high frequency consummation of a food was defined as consumption once or more by a week. Some traditional foods in Moroccan cooking like Harissa (hot red pepper), Qadid (mutton dried and salted), Khlii (dried meat, salted, spiced cooked and preserved in a mixture of oil and rendered beef fat) and Smen (rancid butter) were analyzed in this study. A conditional logistic regression was used to identify the association between dietary factors and the risk of NPC. RESULTS Cases were more likely to have high frequency consumption of Harissa, Smen and Black Pepper, and less frequency consumption of fruts and vegetables. There was significant association between the risk of NPC and the frequency consumption of Qadid, khlii and cooking with olive oil. CONCLUSIONS Some of these risk factors (Harissa, Black pepper) were found in 3 North Africain studies. This study indicates the involvement of dietary factors, and thus the lifestyle in the development of NPC and the need of biochemical analysis of food specimens to search for the carcinogenic agents.
Collapse
|
44
|
Zaidi H, Berhil H, Chenna H, Mouhajir N, El Majjaoui S, El Kacemi H, Hassouni K, Kebdani T, El Gueddari B, Benjaafar N. Cancers primitifs invasifs de la vulve : expérience de l’Institut national d’oncologie de Rabat. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
45
|
Kabbali N, Himmich M, Kebdani T, Hassouni K, El Gueddari B, Benjaafar N. Place de la radiothérapie exclusive dans les paragangliomes non opérables de la tête et du cou, à propos d’une série de dix cas. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Bellefqih S, Khalil J, Mezouri I, Lalya I, Afif M, Jnah L, Hassouni K, Kebdani T, Benjaafar N. Carcinome à cellules indépendantes du rectum : à propos de 16 cas. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
47
|
Chenna H, Nouni K, Berhil H, Zaidi H, El Kacemi H, Hassouni K, Kebdani T, El Gueddari B, Benjaafar N. Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
48
|
Mouhajir N, Hemmich M, Elmajjaoui S, Tolba A, Berhil H, Rami K, Kebdani T, Benjaafar N. Apport de la curiethérapie interstitielle dans le traitement conservateur du cancer du sein : à propos de 38 cas. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
49
|
Khalil J, Lalya I, Afif M, Bellefqui S, Kebdani T, Hassouni K, Gueddari B, Benjaafar N. Sexualité après un cancer du sein : quel impact ? (Expérience marocaine). Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Lachgar A, Diabate K, Khalil J, Hassouni K, Kebdani T, Elgueddari B, Benjaafar N. Traitement antalgique des métastases osseuses symptomatiques par irradiation externe. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|